We have systematically investigated a genetic defect resulting in a primary lipoprotein lipase (LPL) deficiency in a proband TN and his affected brother SN, both manifesting familial hyperchylomicronemia. Neither LPL activity nor immunoreactive LPL mass was detected in postheparin plasma from the two patients. Immunocytochemical and biosynthetic studies on the proband's monocyte-derived macrophages with rabbit antihuman LPL antiserum revealed that no immunochemically detectable LPL protein was found in either the cells or culture medium, whereas LPL having a molecular mass of 61 kD was detected in normal cells. No detectable LPL mRNA was identified from poly(A)+RNA of the proband's macrophages by Northern blot analysis, and grossly visible LPL gene rearrangement was not observed by Southern blot analysis. Sequence analysis of polymerase chain reaction-amplified LPL gene exons detected one base deletion of G (first position of Ala221) at base 916 in exon 5 which leads to a premature termination by a frameshift. This mutation, designated as LPLAi and resulting in the loss of an Alul restriction enzyme site, was newly identified. We further analyzed the LPL gene from the two patients and their family members by digestion with AluL. Both patients were homozygous for LPLAJt allele, while their spouses did not have this mutation. As genetically expected, their children were all heterozygous for LPLmt.. We conclude that primary LPL deficiency in the proband was caused by a lack of enzyme synthesis due to the absence of LPL mRNA resulting from one base deletion ofG in exon 5, and that heterozygous LPLAi. deficient subjects show almost half value of control LPL mass. (J. Clin. Invest. 1992. 89:581-591.)
Introduction
Lipoprotein lipase (LPL,' EC 3.1.1.34) is a glycoprotein enzyme that anchors to the capillary endothelial cell surface with a proteoglycan chain and plays a key role in hydrolyzing the triglycerides ofchylomicrons and very low density lipoproteins at the first step in their metabolism (1, 2) . In these reactions, LPL requires apo C-II as an essential cofactor and produces chylomicron and VLDL remnants, and nascent high density lipoprotein. The resulting lipoprotein remnants are thought to be further catabolized by hepatic triglyceride lipase (HTGL) (3, 4) . Both enzymes are released into the circulation after intravenous injection of heparin. Recently, both lipases were purified from human postheparin plasma (PHP) and characterized (5, 6) . Human PHP-LPL is catalytically active in a monomeric form and its apparent mol wt is 61,000 (6) .
Type I hyperlipoproteinemia is a rare autosomal recessive disorder characterized by severe fasting hypertriglyceridemia including massive accumulation of chylomicrons, normal or marginally increased VLDL, and by decreased low density lipoprotein and high density lipoprotein levels in plasma (7) (8) (9) . Clinically, this disease is usually detected by repeated episodes of abdominal pain, pancreatitis, xanthomatosis, and hepatosplenomegaly. The disorder has been reported to be mainly caused by primary LPL deficiency (8, 9) , primary apo C-II deficiency (8, 9) , or a circulating inhibitor for LPL (9) . In biochemical studies on patients with the primary LPL deficiency as one of the causes, the analysis of LPL activity (8) (9) (10) and quantitation of immunoreactive mass (1 1, 12) in PHP samples are performed as important measures to estimate the pathogenesis of the disease; these measures usually indicate low or absent LPL activity and mass. LPL enzyme takes on a functionally active form at the capillary endothelium through a number of processes, including biosynthesis by extrahepatic parenchymal cells, secretion, transport, and binding to the endothelium (1, 13) . Thus, one or more defects in these processes lead to an abnormality of LPL in PHP, and an individual with such LPL defect(s) is usually diagnosed as exhibiting primary LPL deficiency.
Human LPL cDNA has been cloned and its sequence predicts a molecular wt of 50,394 with 448 amino acid residues in a mature enzyme without sugar moieties (14) . The human LPL gene is identified to be 30 kb in length and consists of 10 exons (15, 16) . Several groups have reported mutations of the LPL gene in patients with primary LPL deficiency. These are gene rearrangements (17, 18) , missense mutations (19) (20) (21) (22) (23) (24) (25) , nonsense mutations (26) , addition of several bases (27) , and mutation in exon-intron boundary region (22) .
In this paper, we describe in detail a genetic defect of LPL gene in patient TN and his brother SN, both with fasting hyperchylomicronemia, and their family members. Both TN and SN were diagnosed as having a primary LPL deficiency by detecting neither LPL activity nor immunoreactive LPL mass in PHP using the selective immunoinactivation assay (SIIA) (6, 12) and the sandwich enzyme immunoassay (EIA) (12) . Biochemical studies revealed neither immunochemically detectable LPL protein nor LPL mRNA from monocyte-derived macrophages of the patient TN. Both patients were homozygous for the LPL gene mutation (LPLAJrit) which was newly identified to be one base deletion of G at base 916 in exon 5, leading to no synthesis of LPL protein due to the absence of LPL mRNA. The patient's children were all heterozygotes carrying one allele of LPLA,,,ia.
Methods
Materials. Human PHP-LPL and human PHP-HTGL enzymes were purified to homogeneity from human PHP according to the method described previously (6) . Pure human PHP-LPL (7. 08 Mmol/h per ml; sp act, 45 mmol/h per mg [12] ) was used as an enzyme source to check whether or not the patient's plasma contained functionally active apo C-II and inhibitors for LPL as indicated in the text. A monospecific, polyclonal antiserum and monoclonal antibody were raised in rabbits and mice against human PHP-LPL and human PHP-HTGL as previously reported (6, 12 ). An HLC601 LPL cDNA probe was prepared from human THP-I (monocytic leukemia cell line) macrophage cDNA library as reported (28) . HLG37-D containing the 3'-noncoding region of the LPL gene was isolated from the human gene library constructed in a lambda dash vector provided by Dr. K. Hiraga, Department of Biochemistry, Toyama Medical and Pharmaceutical University School of Medicine, and was used as a probe.
Subjects and clinical data. The N-family pedigree studied here is shown in Fig. 1 . It consists of four siblings (I-1, -3, -5, and -6 in Fig. 1 Analysis ofplasma lipid, lipoprotein, and apolipoprotein. Plasma was prepared from blood samples collected in tubes containing EDTA2Na (1 mg/ml) after the subjects fasted overnight. Chylomicron and VLDL fractions were obtained from plasma by a quantitative ultracentrifugation at a solvent density of 1.006 g/ml (29) . Triglyceride and cholesterol in plasma, chylomicron and VLDL fractions were measured by the enzymatic method described previously (30) . Apo A-I, A-II, B, C-Il, C-Ill, and E were measured by a single radial immunodiffusion assay (Daiichi Pure Chemicals Co., Tokyo, Japan) according to the supplier's directions.
Measurement of LPL and HTGL activities and immunoreactive masses in plasma. Blood samples, from subjects after an overnight fast, were collected in EDTA-2Na tubes before and 10 min after the injection ofheparin (30 U/kg ofbody weight) for determination ofLPL and HTGL activities as well as masses. Total PHP lipolytic activity, LPL and HTGL activities in PHP were measured with substrate of gum arabic-emulsified tri[9, I0-3H]olein (sp act, 8.93 uCi/humol) by SIIA using rabbit anti-human PHP-LPL antiserum and anti-human PHP-HTGL antiserum as previously reported (6, 12) . The unit of enzyme activity was expressed as micromoles offree fatty acid released per hour per milliliter of enzyme solution unless otherwise mentioned.
The sandwich EIA for LPL mass quantitation was performed by using two distinct types ofanti-human PHP-LPL mAbs that recognize different epitopes on the LPL molecule. The immunoreactive mass of LPL in PHP was specifically measured using a fl-galactosidase-labeled anti-human PHP-LPL mAb ( ( l)D2B2) as an enzyme-linked mAb, an anti-human PHP-LPL mAb (2(10)F8F9) linked with the bacterial cell wall as an insolubilized mAb, and pure human PHP-LPL (0, 100, 200, 300, and 400 ng/ml)as a standard as previously reported (12) . Immunoreactive mass of HTGL in PHP was also measured by the sandwich EIA using the combination of two distinct types of mAbs, such as ( ,B-galactosidase-labeled anti-human PHP-HTGL mAb (2(4)F12C12) and an anti-HTGL mAb linked with the cell walls (1(1 1)A3H3) (12 Assay ofLPL activity derivedfrom macrophages. The medium was harvested from the macrophages cultured in the 35-mm dishes containing 1 ml of growth medium at the time indicated in the text. The cells were harvested with 3 ml of RPMI 1640 medium containing 10% FCS and protease inhibitors (0.1 mM PMSF, 0.1 mM leupeptin, 0.01 mM pepstatin A, and 0.6 MM aprotinin). The cell suspensions were centrifuged at 1,800 g for 10 min and the cell pellets were dissolved in 0.1 ml of 20 mM phosphate buffer, pH 7.4, containing 10% glycerol, 1 mM EDTA, 0.15% n-octyl-D-thioglucoside, heparin (50 ,ug/ml), and the same protease inhibitors as above. The cell suspension was sonicated three times for 1 min at intervals of 1 min in an ice bath. LPL activity in the medium and cell lysate (0.1 ml each) was quantitated under the same method described above. For determination of cell proteins, cells were solubilized with 1 ml of 0.1 N NaOH solution and the protein concentrations were measured by the method of Lowry et al. (31) .
Immunocytochemical procedures. Monocyte-derived macrophages (1.5 X 106 cells/dish) in 35-mm dishes were fixed for 20 min with methanol containing 0.3% H202, followed by blocking with 5% normal goat serum/PBS solution for 20 min. The cells were incubated for 1 h with rabbit anti-human PHP-LPL antiserum (1/1,000) diluted by 1.5% normal goat serum/PBS solution (dilution buffer). After 1 h incubation, the cells were incubated for 0.5 h with 1 ml ofbiotinylated goat anti-rabbit IgG (Vector Laboratories, Inc., Burlingame, CA) in the dilution buffer, reacted with 1 ml of avidin/biotinylated horseradishperoxidase complexes (Vector Laboratories) in the dilution buffer, and then stained for 20 min with 0.02% of 3-amino-9-ethylcarbazole (AEC)/0.01% H202 in 50 mM acetate buffer. In control experiments, the cells were incubated with nonimmune rabbit serum (1/1,000) dissolved in the dilution buffer, followed by the subsequent procedures mentioned above. After AEC reaction, nuclei were stained with Mayer's hemalum solution. Photographs were taken using an Olympus (Vanox S) light microscope. Immunocytochemical detection of apo E in macrophages was also performed with rabbit anti-human apo E antiserum (a gift from Daiichi Chemical Co., Tokyo) under the same methods described above.
Labeling ofmacrophages in culture. The monocyte-derived macrophages in the 35-mm dishes were washed twice with PBS and then incubated for 1 h in 1 ml of labeling medium (methionine-depleted Eagle's minimum essential medium containing 10% dialyzed FCS). The medium was replaced with 1.5 ml of fresh medium containing 100
MCi of L-[355]methionine (Amersham Corp., Arlington Heights, IL).
The dishes were incubated at 37°C for the time indicated in the text. The medium (1.5 ml) was harvested and mixed with 0.15 ml of 0.1 M Tris buffer (pH 7.4) containing 0.1 M EDTA, 5% Triton X-100, and 2.5% SDS. The mixture was subjected to immunoprecipitation. The cells were first washed twice with PBS and solubilized with 2 ml ofthe lysis buffer (10 mM Tris buffer, pH 7.4, containing 150 mM NaCI, 10 mM EDTA, 0.5% Triton X-100, 0.25% SDS, and 1% unlabeled methionine) as described in our previous papers (32, 33) . The cell lysate was centrifuged at 356,000 g for 10 min using an Ultracentrifuge (TL-100; Beckman Instruments, Palo Alto, CA) and the supernatant was subjected to immunoprecipitation.
Immunoprecipitation ofradiolabekedLPL and ekectrophoresis. The culture medium and cell lysate solubilized in the lysis buffer were mixed with 7 Ml of rabbit anti-human PHP-LPL antiserum or 10 M1 of rabbit anti-human apo E antiserum. The mixtures were incubated for 12 h at 4°C. The immunocomplexes were recovered by adding 100 Ml of Staphylococcus aureus cell suspension (10%, wt/vol) (Bethesda Research Laboratories, Gaithersburg, MD) followed by centrifugation at 1,700 g for 5 min (32, 33) . The pellets were washed three times with 2 ml of 10 mM Tris buffer (pH 7.4) containing 150 mM NaCl, 0.1% SDS, 1.0% Triton X-100, and 1.0% deoxycholate. The washed immunoprecipitates were solubilized in 25 Ml of0.1 M Tris buffer (pH 6.8) containing 3% SDS, 37% glycerol, 33 mM dithiothreitol, and 0.019% bromophenol blue and boiled for 5 min (32) . The sample mixtures were centrifuged at 4,000 g for 10 min, and then the supernatant was subjected to a slab SDS-PAGE with 10% gel according to the method ofLaemmli (34) . The gel was stained with Coomassie blue, destained, and treated for fluorography with Autofluor (National Diagnostics, Inc., Somerville, NJ) (33). The radiolabeled protein bands were visualized on Kodak XAR-5 x-ray film after exposure at -800C. The subunit molecular mass was estimated using the following marker proteins: phosphorylase B (94 kD), bovine serum albumin (68 kD), ovalbumin (46 kD), carbonic anhydrase (30 kD), soybean trypsin inhibitor (21 kD), and lysozyme (14 kD).
Northern and Southern blot analysis. Total cellular RNA was prepared from macrophages, cultured in the 100-mm dishes, of normal subjects and proband TN. Cells were lysed in 4 M guanidine isothiocyanate buffer and centrifuged through a cesium chloride gradient to isolate total RNA (35) . Poly(A)+RNA was then isolated from the total RNA by oligo (dT)-cellulose column chromatography (35) . An aliquot of 6.8 Mg of poly(A)+RNA was denatured in formaldehyde/formamide and electrophoresed in a formaldehyde-containing 1.0% agarose gel (35) . RNA was transferred to a membrane of GeneScreen Plus (Dupont-NEN, Boston, MA) overnight, and hybridized with 32P-labeled HLC601 LPL cDNA (32-1643) containing the complete coding region of human LPL cDNA (28) or 32P-labeled chicken #-actin cDNA (36) .
Prehybridization, hybridization, and washing were performed according to the standard procedure (35) .
Genomic DNA was isolated from peripheral mononuclear cells of normal subjects, the two patients (TN and SN) and their family members as described (35) . Southern blot analysis was performed on DNA separated by 1.0% agarose electrophoresis after digestion with the appropriate restriction enzymes, followed by transfer to a GeneScreen Plus membrane and hybridization with 32P-labeled HLC601 or 32P-labeled HLG37-D (1629-3154 of human LPL cDNA) according to the standard procedure (35) . The blotted sheets were exposed to Kodak XAR-5 film for several days at -80°C with intensifying screens.
Cloning and sequencing ofthe genomic DNA ofproband TN. DNA containing each exon and exon-intron boundary, and the 5' upstream region of the LPL gene were enzymatically amplified from the genomic DNA of proband TN by a DNA Thermal Cycler (Perkin-Elmer Cetus Instruments, Norwalk, CT) using 20 pmol of each pair of primers described below and 5 U of Taq DNA polymerase (37, 38) . The reaction mixtures were denatured at 94°C for 10 min before addition of Taq DNA polymerase. The polymerase chain reaction (PCR) was performed with 1 min denaturation at 94°C, 1 min primer annealing at 55°C, and 2 min extension at 72°C. Amplified DNA was purified by a Geneclean Kit (BIO 101, Inc., La Jolla, CA) according to the supplier's directions. The purified DNA was digested with PstI and BamHI, and cloned into the Bluescript SK II Ml 3(-) vector (Stratagene Inc., La Jolla, CA), while DNA blunted with T4 DNA polymerase was also cloned into the same vector. DNA sequencing was performed by the dideoxynucleotide chain termination method of Sanger et al. (39) .
Primers were synthesized by a DNA synthesizer (380 A; Applied Biosystems, Inc., Foster City, CA) and are listed below: DNA including 5' upstream region, and each exon and exon-intron boundary was amplified with Exon-IF (5'-GCCGGATCCAAATGGAA- 
Results
Plasma lipid, lipoprotein, and apolipoprotein profiles ofN-family
As shown in Table I , proband TN (I-1) and his brother SN (1-3) exhibited fasting hyperchylomicronemia with triglycerides (7, 8) . Two of their children (11-3 and -4) exhibited type IV hyperlipoproteinemia as a phenotype reported (7, 10) . or more than normal range (3.4±1.3 mg/dl, mean±SD) and the biological function of apo C-I1 was determined to be normal by the observation that two patients' plasma activated pure human PHP-LPL enzyme in vitro.
Analysis ofLPL and HTGL activities and masses in PHP Table II shows LPL and HTGL activities and masses in preheparin plasma and PHP from the N-family members and nor- incubation of the macrophages, the growth medium was replaced with 1 ml of fresh growth medium. Immunocytochemical detection ofLPL in macrophages ofproband TN and a normal subject
Monocyte-derived macrophages of a normal subject and proband TN were cultured for eight days and fixed with a methanol solution. After the fixation, macrophages were reacted with rabbit anti-human PHP-LPL antiserum or anti-human apo E antiserum. As shown in Fig. 2 , LPL proteins in normal macrophages (A) were well stained and localized in the perinuclear area in all cells. In the case of proband TN, however, no LPL proteins were detected in any cells (C), suggesting that macrophages of proband TN did not have the ability to produce LPL proteins. In contrast, macrophages of proband TN could synthesize apo E proteins and they were clearly detected in the perinuclear area (E). With nonimmunized rabbit serum, no LPL proteins in macrophages were stained at all as shown in B and D, and no apo E proteins in F.
Molecular nature ofLPL synthesized and secreted by macrophages ofproband TN and hisfamily, and a normal subject LPL activity derivedfrom macrophages. LPL activities secreted from macrophages of proband TN and his family members, and a normal subject were examined after one day each in culture for eight days (Fig. 3 A) . LPL activities from proband TN were not detected through culture for eight days, while LPL activities from his spouse KN were almost the same as those of the normal subject. LPL activities from daughter EN and son YN were almost half of the normal subject. Furthermore, to avoid the possibility that the secreted proband TN's LPL was inactivated by long incubation (24 h ) at 370C, we examined LPL activities secreted in short incubation (1-7 h) from the macrophages obtained at the eighth day of culture (Fig. 3 B) . Again, no LPL activities were detected from the proband even in the short time incubation, whereas LPL activities from the proband's family members and a normal subject were linearly accumulated until at least 3 h. In addition, no intracellular LPL activity was observed from the macrophages of the proband, Fig. 4 . In the normal subject (Fig. 4 A) , a sharp single labeled LPL proteinin bnd was detected in cell ly- 3 and 4) . These bands were ascertained to be LPL protein bands by competition and control experiments. The labeled LPL bands diminished in the presence of excess pure human PHP-LPL before the addition of the antiserum (lanes 5 and 11). Also, these protein bands were not detected by the addition of nonimmune rabbit serum (lanes 6 and 12). The subunit molecular mass ofthe labeled LPL (61 kD) in both the culture medium and cell lysate was almost identical to that (61 kD in lane 13) of pure human PHP-LPL. In contrast, proband TN's macrophages exhibited no detectable labeled LPL protein bands in both culture medium (lanes 3-5 in Fig. 4 B) and cell lysate (lanes 9-11 in Fig. 4 B) at any ofthe pulse-labeling times even in four times longer exposure of x-ray film than that of normal macrophage experiment, although the proband's macrophage proteins were well labeled with [35S]methionine (lane 14 in Fig. 4 B) . In the proband's experiment (Fig. 4 B) , it should be noted that protein bands visualized in cell lysates labeled for 3 and 5 h (lanes 10 and 11) were determined to be nonspecific, because those bands were nonspecifically observed in both competition (lane 12) and control (lane 13) experiments.
In the proband's family study (Fig. 5 A) , the LPL protein band from spouse KN (lanes 9 and 11) was nearly the same as that ofthe normal subject (lanes I and 3) in its molecular mass (61 kD) and intensity, indicating that spouse KN was normal for the ability to synthesize and secrete LPL. As expected, the labeled LPL protein bands from son YN (lanes 13 and 15) and daughter EN (lanes 17 and 19) were approximately half of the amount of LPL from the normal subject in both medium and cell extracts. As a control experiment (Fig. 5 B) , the molecular nature of apo E synthesized and secreted by macrophages of the normal subject and the proband's family was examined using rabbit anti-human apo E antiserum. All tested members including proband TN showed apo E proteins (odd number lanes in lanes [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] which were the same as that ofthe normal subject (lanes I and 3) in their molecular mass (38 medium and 36 kD in the cell lysate) and intensity. Together with the observations from the immunocytochemical studies (Fig. 2 ), these data demonstrate that proband TN should be determined as having the disability to synthesize the LPL molecule, while the fact that apo E is normally produced in the proband suggests that other proteins might not be affected.
Northern and Southern blot analysis ofproband TN
Northern blot analysis of poly(A)+RNA isolated from monocyte-derived macrophages ofproband TN, and normal subjects YI and AY was carried out with 32P-labeled HLC601 LPL cDNA. As shown in Fig. 6 A, proband TN showed no detectable amount of LPL mRNA (lane 2), while almost equal amounts of two species of mRNA (3.4 kb and 3.8 kb) were detected in the macrophages of the two normal subjects (lanes I and 3). As a control experiment, the same membrane was treated to remove the HLC601 probe and was rehybridized with a 32P-labeled chicken f3-actin cDNA probe. The proband (lane 2) and two normal subjects (lanes I and 3) yielded almost equal amounts of fl-actin mRNA (Fig. 6 B) .
To examine the gross structure of proband TN's LPL gene, the digestion pattern ofgenomic DNA with PvuII, BamHI and HindIII was studied by Southern blot analysis with a 32P-la- nucleotide variant from the normal entire cording exon was identified in exon 5; all five clones possessed one base deletion of G (it is noted as a C base deletion of the antisense strand of exon 5 in Fig. 7 A) , which is the first position ofthe GCT codon for alanine at position 221 in a normal allele (Fig. 7 B) , at nucleotide position 916 in exon 5. The one base deletion generates a stop codon (TGA) at position 224 within exon 5 by a frameshift (Fig. 7 B) , and resulted in the loss of an AluI restriction enzyme site present in the normal LPL gene (Fig. 7 B) . (Fig. 8 A) . As shown in Fig. 8 (27) : one is derived by C to T transition at base 571 in exon 3 id is missing an (26) , and the other is from an addition of 5 bp in exon 3 (27) and stability ofmRNA has extensively studied on patients with N t-thalassemia (42, 43) . A similar finding to ours has been identified in the 3-grobin gene of a patient with ,3°-thalassemia: one base deletion of C was detected in exon 2 of f3-grobin gene containing three exons, leading to a premature termination asis of primary within exon 2 by a frameshift, and resulting in no detectable perlipoprotein-,B-grobin mRNA (42, 43) . It is interpreted that the total lack of ,active mass in 3-globin mRNA resulted from the rapid degradation of the ized by mono-mature (3-globin mRNA with a hypothesis that the portion of ect of the LPL mRNA distal to the nonsense mutation is hypersusceptible to d revealed neidegradation (43) . at the proband
In the N-family study, through the digestion test of LPL ome defects by gene with AluM enzyme, the proband's brother SN was also creted or transconfirmed to be homozygous for the LPL,, allele as expected vhich processes from the observations that he exhibited neither LPL activity monocyte-denor immunoreactive mass in PHP the same as the proband. In es of LPL proconsideration ofthe reported consanguinity between their pare cells, because ents, these two LPLAit,, alleles are likely to be identical by de--asily obtained scent. The proband's spouse was determined to be normal, r immunoreacbecause she was not a carrier ofthis type ofLPL mutation, and ure medium or her LPL activity and mass in PHP and newly synthesized LPL )chemical stud-protein in macrophages were all within the normal range. As 'nthetic experi-genetically expected, the proband's children were all heterozyin having a mo-gotes, carrying one allele of LPLAiJ,, which was in good agree-ment with the data of approximately half the values of the control in the quantitations of LPL in PHP and LPL protein synthesized by macrophages. In the family of affected brother SN, his spouse was normal and their children were all heterozygous for LPL,,,iJ the same as in the proband's family. The Nfamily, which does not show a history of symptoms leading to secondary hyperlipoproteinemia, is an informative model to study the relationship between the heterozygosity for LPL deficiency and lipoprotein abnormalities. In fact, two ofthe tested five children exhibited type IV hyperlipidemia, suggesting that this type of hyperlipidemia is closely related to the heterozygous state for LPL deficiency.
In this paper we have shown an approach to identify molecular defects ofLPL in the patients with primary LPL deficiency by systematically investigating the molecular basis ofLPL. The combination oftwo procedures, such as the SIIA and sandwich EIA methods to quantitate LPL activity and mass in PHP, and immunochemical quantitations of LPL in the cultured macrophages, were powerful in estimating defects of the LPL molecule. These data together with LPL gene information (14, 15, 16, 40) led us to finally identify the LPLAriJ allele. The sequence of LPL~,ia provided by this study should be useful to screen hyperlipidemic patients for the presence of LPLAJ,,J allele based on the primary information of LPL defect obtained by both the SIIA and sandwich EIA methods.
